Cogent Biosciences (COGT) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Cogent Biosciences, as the data feed reports them.

Analysts' mean target, 11 analysts
$55.82
100.4% above the price

The 11 analysts reported by the data feed have a mean price target for Cogent Biosciences of $55.82, 100.4% above the $27.85 price (range $45.00–$61.00). 10.07% of the float was sold short as of Oct 30, 2026. Institutions hold 117.6% of the shares and insiders 0.4%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$55.82+100.4% vs price
Analysts
11
Short interest
10.07%of float, Oct 30, 2026
Short ratio
8.16 days
Institutions
117.6%
Insiders
0.42%
Beta
0.34

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

11 analysts covering Cogent Biosciences, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $27.85.

Analysts' price targets for Cogent Biosciences
Mean price target$55.82100.4% above the price (+100.4%)
Median price target$55.0097.5% above the price (+97.5%)
Highest target$61.00119.0% above the price (+119.0%)
Lowest target$45.0061.6% above the price (+61.6%)
Analysts with a target11

Ratings this month · 12 analysts

Strong buy 2(17%)Buy 9(75%)Hold 1(8%)
Analysts' ratings of Cogent Biosciences this month, by rating
RatingAnalystsShare
Strong buy217%
Buy975%
Hold18%
Sell00%
Strong sell00%

The feed averages these to 1.33 on its scale of 1 (strong buy) to 5 (strong sell), which it labels “strong buy”.

Who owns Cogent Biosciences

Ownership of Cogent Biosciences
Held by institutions117.6%426 institutions; percent of shares outstanding
Held by institutions, of the float118.1%
Held by insiders0.42%percent of shares outstanding
Shares outstanding173.99M
Float173.03Mshares available to trade
Insiders' net purchases, six months+160K2 purchases (205.51K shares), 1 sales (45.51K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Cogent Biosciences
Shares short17.42Mas of Oct 30, 2026
Percent of float10.07%shares short ÷ float
Percent of shares outstanding10.01%shares short ÷ shares outstanding
Short ratio (days to cover)8.16shares short ÷ average daily volume

Cogent Biosciences short interest from FINRA, with its history

Trading figures

Trading figures for Cogent Biosciences
Beta0.34movement against the market; 1 moves with it
52-week high$43.73
52-week low$26.36
Average volume, 3 months2.02Mshares a day
Average volume, 10 days2.18Mshares a day

Questions and answers

What is the analysts' price target for Cogent Biosciences (COGT)?

As reported by the data feed, the mean price target of the 11 analysts covering Cogent Biosciences is $55.82, 100.4% above the latest price of $27.85. The highest target is $61.00 and the lowest $45.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Cogent Biosciences stock?

Of the 12 ratings the data feed reports for the current month, 2 are strong buy, 9 buy, 1 hold, 0 sell and 0 strong sell.

How many Cogent Biosciences shares are sold short?

As reported by the data feed, 17.42M shares were sold short, 10.07% of the float as of Oct 30, 2026. At the average daily volume that is 8.16 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Cogent Biosciences stock?

As reported by the data feed, institutions hold 117.6% of the shares (426 institutions) and insiders 0.4%. There are 173.99M shares outstanding, of which 173.03M are in the float.

How much does Cogent Biosciences stock move with the market?

Its beta, as reported by the data feed, is 0.34: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $26.36 and $43.73.

Cite this page

Funkfolio, “Cogent Biosciences (COGT) statistics and analyst targets”, data as of 17 November 2026. https://funkfolio.com/stock/COGT/statistics

Underlying data: Yahoo Finance.